About the Alliance Anticoagulation Foundation
The BMS-Pfizer Alliance is a collaboration between Bristol-Myers Squibb Pharmaceuticals Ltd and Pfizer Ltd. The Alliance Anticoagulation Foundation takes the format of a website and has been created and is funded by the BMS-Pfizer Alliance. Its purpose is to provide information about how we collaborate with and support the NHS and other healthcare organisations in order to advance patient care and achieve the best outcomes for patients in the UK.
On this website, you will find past examples of our work with the NHS and other healthcare organisations, as well as information about how you can request support from the BMS-Pfizer Alliance. This support might take the format of a Medical and Educational Goods and Services (MEGS) agreement.
Front basic pages
Medical and Educational Goods and Services (MEGS)
The BMS-Pfizer Alliance is committed to supporting healthcare professionals and the NHS to drive improvements in patient care and help achieve the best results for patients.
Working with the BMS-Pfizer Alliance
The BMS-Pfizer Alliance has experience of working in partnership with the NHS, healthcare organisations and patient associations.
The NHS is constantly changing and the needs of our partners and the people they care for reflect this. At such a challenging time for our health service, the BMS-Pfizer Alliance has established the Alliance Anticoagulation Foundation as part of our commitment to working in partnership with the NHS and other healthcare organisations in order to improve outcomes for patients. This website, therefore, sets out ways in which we can achieve optimal care for patients requiring anticoagulation through a number of routes, which could include: collaborative working and support; pooling skills, experience and resources; and financial grants or services.